TickerFactsScreenerDevelopers

Coherus Oncology, Inc. (CHRS) — Net Income

Annual figures by fiscal year, from SEC filings.

2012: -$33.02M2013: -$53.63M2014: -$87.13M2015: -$223.26M2016: -$127.34M2017: -$238.17M2018: -$209.34M2019: $89.83M2020: $132.24M2021: -$287.10M2022: -$291.75M2023: -$237.89M2024: $28.51M2025: $168.02M$168.02M
2012Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025$168.02M+489.4%
2024$28.51M+112.0%
2023-$237.89M+18.5%
2022-$291.75M-1.6%
2021-$287.10M-317.1%
2020$132.24M+47.2%
2019$89.83M+142.9%
2018-$209.34M+12.1%
2017-$238.17M-87.0%
2016-$127.34M+43.0%
2015-$223.26M-156.2%
2014-$87.13M-62.5%
2013-$53.63M-62.4%
2012-$33.02M—